Reccan AB

Reccan AB, a health tech startup founded in 2014 in Sweden, has been making waves in the medical industry with its breakthrough in the detection of pancreatic cancer. With the slogan "A breakthrough in the detection of pancreatic cancer," the company aims to improve the prognosis for patients diagnosed with this deadly disease. Reccan is dedicated to pioneering early diagnosis, believing it is the key to a better prognosis for pancreatic cancer patients. The company's vision is clear: setting a standard for early detection of pancreatic cancer to save lives. By finding the cancer at an earlier stage than currently possible, Reccan is working towards changing the trajectory of pancreatic cancer mortality. Early detection not only provides a better chance for effective interventions but also enhances the effectiveness of treatments. The most recent milestone for Reccan occurred with its Venture Round investment on 08 September 2020, with LU Innovation as the primary investor. This marks a significant step for the company as it strives to bring its vision to fruition and make a tangible impact in the realm of medical technology. With a promising outlook and a clear focus on addressing a critical health issue, Reccan AB is a company to watch in the coming years.